Patient-identified early clinical warning signs of nodular melanoma: a qualitative study

HIGHLIGHTS

• who: Adina Coroiu from the The study was approved by the Institutional Research Board (IRB) of Harvard TH. Chan School of Public Health and the Research Ethics Board (REB) of McGill University, which are in agreement with the Declaration of Helsinki. Eligibility for the study included a confirmed diagnosis of either NM or SSM and receiving treatment at the Masachussets General Hospital between , and, . Eligible participants were identified through medical hospital records and included men and women diagnosed with thin (≤ , mm) and thick (> , mm) NM and SSM. We identified all eligible NM patients (n=109) and matched . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.